In conclusion, our findings suggest that the Hb/Cr ratio may represent a simple yet informative marker of increased risk in STEMI patients, capturing the combined burden of anemia and renal dysfunction—two conditions that, even when mild, appear to synergistically worsen prognoses. The gene discussed is GSTM1; the disease is anemia.